Copley Scientific has announced the launch of the BAC 2100 Breath Actuation Controller for automated flow control during cascade impaction and delivered dose uniformity testing of metered dose inhalers. The company is also launching the BAC 2100-R, with reversed flow inlet and outlets.
The new versions of the BAC include automated cascade impactor leak testing, an updated menu system, and a time delay feature for actuation of MDIs used with spacers and valved holding chambers in accordance with USP Chapter <1602>. An MDI actuation sensor that attaches to the MDI canister is available as an optional accessory.
Copley Scientific Business Development Manager Anna Sipitanou said, “After the successful launch of our new TPK 2100 we identified the value of transferring much of the technology across to MDIs, where recent additions to the USP chapters relating to MDIs call for a range of parameters to be controlled and monitored, like for DPIs. This need led us to the creation of BAC 2100 which has been designed specifically for assisting analysts to perform MDI testing in a consistent and reproducible manner, but also eases the process of moving a drug application forward by satisfying regulators with robust data reporting functions. We can see the BAC 2100 becoming the new benchmark for MDI testing.”
Read the Copley Scientific press release.
